AVXL Anavex Life Sciences
- 3.440
- +0.050+1.47%
- 3.420
- -0.020-0.58%
Anavex Life Sciences News
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Skarpelos Athanasios
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Ma Jiong
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Velden Claus Vander
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Thomas Steffen
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Donhauser Peter D.O.
Anavex Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.31%)
Anavex Life Sciences | 10-Q: Quarterly report
Anavex Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.1%)
Anavex Life Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(4.44%)
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Boenisch Sandra
Anavex Life Sciences: FY2023 Annual Report
Anavex Life Sciences | 10-Q: Q3 2023 Earnings Report
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Anavex Life Sciences | 8-K: Current report
Anavex Life Sciences | 10-Q: Q2 2023 Earnings Report
Anavex Life Sciences | 8-K: Current report
Analysis
Price Target
No Data
